How do physician assessments of patient preferences for colorectal cancer screening tests differ from actual preferences?
Author InfoDeborah A. Marshall F. Reed Johnson (Research Triangle Institute, Research Triangle Park, NC, USA) Nathalie A. Kulin Semra Ă–zdemir (Research Triangle Institute, Research Triangle Park, NC, USA) Judith M. E. Walsh John K. Marshall (Department of Medicine (Division of Gastroenterology), McMaster University, Hamilton, Ont., Canada) Stephanie Van Bebber (School of Pharmacy, University of California, San Francisco, CA, USA) Kathryn A. Phillips (School of Pharmacy, University of California, San Francisco, CA, USA) Abstract Background: Patient preferences can affect colorectal cancer (CRC) screening test use. We compared utility-based preferences for alternative CRC screening tests from a stated-preference discrete-choice survey of the general population and physicians in Canada and the United States. Methods: General population respondents (Canada, n=501; US, n=1087) participated in a survey with 12 choice scenarios and 9 CRC screening test attributes. Physicians (n=100, both Cana